The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 16, 2019

Filed:

Jun. 23, 2015
Applicant:

Jw Creagene Inc., Gyeonggi-do, KR;

Inventors:

Yong-Soo Bae, Gyeonggi-do, KR;

Jun-Eui Park, Gyeonggi-do, KR;

Yun-Ju Woo, Gyeonggi-do, KR;

Jin-Ah Jang, Gyeonggi-do, KR;

Assignee:

JW CREAGENE INC., Gyeonggi-Do, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/071 (2010.01); C12N 5/00 (2006.01); C12N 5/02 (2006.01); A61K 39/00 (2006.01); A61K 35/12 (2015.01); C12Q 1/68 (2018.01); C12N 5/0784 (2010.01); C12Q 1/6881 (2018.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0008 (2013.01); A61K 35/12 (2013.01); C12N 5/0639 (2013.01); C12Q 1/68 (2013.01); C12Q 1/6881 (2013.01); G01N 33/56977 (2013.01); A61K 2039/5154 (2013.01); C12N 2501/02 (2013.01); C12N 2501/25 (2013.01); C12N 2501/998 (2013.01); C12Q 2600/158 (2013.01);
Abstract

The present invention relates to a method for generating semi-mature dendritic cells by treating immature dendritic cells with the auto-antigen, cytokine, and PGE2 as a target for the treatment of autoimmune diseases, particularly rheumatoid arthritis, in which the levels of NR4A2 and/or UBASH3B at gene or protein are increased more than 2-fold compared to the immature dendritic cells In addition, the present invention relates to a cell therapeutic agent for treating or preventing autoimmune diseases, containing the semi-mature dendritic cells as an active ingredient. The present invention increases the therapeutic efficacy on rheumatoid arthritis retaining responsiveness to the same auto-antigen that being used for preparing semi-mature dendritic cells, thereby enabling cell therapy.


Find Patent Forward Citations

Loading…